Search Orphan Drug Designations and Approvals
-
Generic Name: | FTV1+GDP-fucose |
---|---|
Date Designated: | 03/18/2011 |
Orphan Designation: | To improve homing to bone (treatment of myeloablation) in patients receiving hematopoietic stem cell transplantation. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
America Stem Cell, Inc. 11014 Bar X Trail Helotes, Texas 78023 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-